1. Home
  2. AVDL vs MCBS Comparison

AVDL vs MCBS Comparison

Compare AVDL & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • MCBS
  • Stock Information
  • Founded
  • AVDL 2015
  • MCBS 2006
  • Country
  • AVDL Ireland
  • MCBS United States
  • Employees
  • AVDL N/A
  • MCBS N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • MCBS Major Banks
  • Sector
  • AVDL Health Care
  • MCBS Finance
  • Exchange
  • AVDL Nasdaq
  • MCBS Nasdaq
  • Market Cap
  • AVDL 784.6M
  • MCBS 745.5M
  • IPO Year
  • AVDL 1996
  • MCBS 2019
  • Fundamental
  • Price
  • AVDL $9.18
  • MCBS $27.08
  • Analyst Decision
  • AVDL Strong Buy
  • MCBS Hold
  • Analyst Count
  • AVDL 6
  • MCBS 1
  • Target Price
  • AVDL $18.17
  • MCBS $34.00
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • MCBS 30.6K
  • Earning Date
  • AVDL 08-07-2025
  • MCBS 07-18-2025
  • Dividend Yield
  • AVDL N/A
  • MCBS 3.38%
  • EPS Growth
  • AVDL N/A
  • MCBS 30.91
  • EPS
  • AVDL N/A
  • MCBS 2.58
  • Revenue
  • AVDL $194,450,000.00
  • MCBS $143,775,000.00
  • Revenue This Year
  • AVDL $56.88
  • MCBS $16.00
  • Revenue Next Year
  • AVDL $29.81
  • MCBS $31.75
  • P/E Ratio
  • AVDL N/A
  • MCBS $10.42
  • Revenue Growth
  • AVDL 252.64
  • MCBS 19.70
  • 52 Week Low
  • AVDL $6.38
  • MCBS $24.00
  • 52 Week High
  • AVDL $17.30
  • MCBS $36.15
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 47.63
  • MCBS 42.39
  • Support Level
  • AVDL $9.10
  • MCBS $27.14
  • Resistance Level
  • AVDL $9.76
  • MCBS $28.90
  • Average True Range (ATR)
  • AVDL 0.47
  • MCBS 0.57
  • MACD
  • AVDL -0.08
  • MCBS -0.12
  • Stochastic Oscillator
  • AVDL 14.29
  • MCBS 14.55

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

Share on Social Networks: